|
The Pharmaceutical Compliance Forum's 23rd Pharmaceutical & Medical Device Ethics and Compliance Congress Announces Agenda-at-a-Glance & OIG Senior Counsel Mary Riordan, JD Keynote Address
|
- A Hybrid Onsite Conference and Internet Event
- Sponsored by Pharmaceutical Compliance Forum
- Media Partners: Policy & Medicine Compliance Update
- October 24-26, 2022
- Capitol Hyatt, Washington, DC
- www.PharmaCongress.com
PRESS RELEASE
Phone: 800-503-7419
Email: reginfo@hcconferences.com
Website: www.PharmaCongress.com |
|
FEATURING KEYNOTE ADDRESS BY
|
Mary E. Riordan, JD
Senior Counsel, Office of Counsel to the Inspector General, Office of the Inspector General, US Department of Health and Human Services, Washington, DC
|
|
|
|
REGISTER BY 8/26 FOR EARLY BIRD RATE
|
|
Click Here for discounted registration.
|
|
|
AGENDA-AT-A-GLANCE NOW AVAILABLE
|
|
Click Here for Agenda-at-a-Glance..
|
|
|
FEATURING
|
- We are thrilled to welcome you back to Washington DC for the in-person/hybrid PCF Congress!
- Join us live to take advantage of numerous interpersonal networking opportunities with colleagues and educational opportunities at our robust exhibit hall with our industry partners
- An invitation-only, closed-door Chief Compliance Officer (CCO) Roundtable on the morning of Tuesday, October 25
For more information contact pcf.org.info@gmail.com.
- Annual reports and updates provided by DOJ, FDA, and OIG
- Over 30 current topics addressing crucial ethics, compliance and legal issues
- An industry-only, closed-door session for pharma and device ethics, compliance and legal professionals on Wednesday, October 26
|
|
|
WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE™ -- AUGUST 8, 2022: The Pharmaceutical Compliance Forum (PCF) executive committee is pleased to announce that the Twenty-Third Pharmaceutical & Medical Device Ethics and Compliance Congress is returning to the Hyatt Regency on Capitol Hill in Washington, DC on October 24-26, 2022.
|
|
NEWLY CONFIRMED KEYNOTE SPEAKERS
|
Catherine (Katie) Gray, PharmD
Acting Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Baltimore, MD |
Glenn Leon, JD
Incoming Fraud Section Chief, Criminal Division, US Department of Justice; Former SVP & Chief Ethics & Compliance Officer, Hewlett Packard, Washington, DC |
Mary E. Riordan, JD
Senior Counsel, Office of Counsel to the Inspector General, Office of the Inspector General, US Department of Health and Human Services, Washington, DC
|
Julie Ritchie Wagner, JD
Senior Assistant General Counsel, PhRMA; Former Senior Counsel, HHS Office of Counsel to the Inspector General, Washington, DC |
Jamie Yavelberg, JD
Director, Fraud Section, Civil Division, US Department of Justice, Washington, DC
|
|
|
FEATURED FACULTY
|
Meredith S. Auten, JD
Partner, Morgan, Lewis & Bockius LLP |
Kristiana Bankova, MS
Senior Manager Forensics, EY |
Samantha Barrett Badlam, JD
Counsel, Ropes & Gray
|
Eric M. Baim, MA, JD
Partner, Dovetail Consulting Group LLC; Former VP Compliance US, Shire |
Ann E. Beasley, JD
Chief Compliance Officer, Zai Lab |
Allison Benkert, MBA
Director Global Compliance Investigations, Seagen
|
Jennifer Bragg, JD
Partner, Skadden Arps LLP |
Adam L. Braverman, JD
Partner, Morrison & Foerster, Former US Attorney, Southern District of California |
Terra Buckley, JD
VP, Head of Compliance Advisory Services, MedPro Systems; VP Compliance, Mesoblast
|
Craig Carpenito, JD
Partner, King & Spalding; Former US Attorney, New Jersey |
Steven Cohen, MBA
Associate Vice President & Chief Ethics and Compliance Officer, North America and Canada, Eli Lilly |
Jake DeBoever, JD
Vice President, Chief Compliance Officer, Dermavant Sciences
|
Gildas Durand
Partner/Principal, Forensic & Integrity Services, EY |
David Falcone
Associate Vice President Global Compliance, Merz Aesthetics |
J. Mark Farrar, CPA, CFE, CFF, MSJ, CIPP/US
Managing Director, Epsilon Life Sciences LLC
|
Bethany Fox, JD
Vice President, Commercial Legal Affairs, Exelixis |
Sara Frank, JD
Principal, Choate, Hall & Stewart LLP |
Nereyda Garcia, JD
Head, Ethics & Compliance, US Business Unit, Takeda
|
Gary F. Giampetruzzi, JD
Partner, Paul Hastings |
Edward P. Glynn, MBA
Principal, EY |
Gejaa T. Gobena, JD
Partner, Hogan Lovells; Former Deputy Chief, Fraud Section, Criminal Division, USDOJ
|
Tom Gregory
Partner, Forensic & Integrity Services, EY |
Noor Haq, CCEP, MS, MBA, CIA
Executive Director, US Compliance, Amgen |
Saul B. Helman MD, MBA
President, Epsilon Life Sciences
|
Michael Hercz, JD
SVP & General Counsel, Sentynl |
Emily F. Hodge, JD
Partner, Choate, Hall & Stewart LLP |
Andrea Kocharyan, JD
Vice President, Head of Legal and Compliance, Zealand Pharma
|
Daniel Koerner
Senior Director, Potomac River Partners |
Michael K. Loucks, JD
Partner, Skadden Arps LLP; Former Acting US Attorney, Massachusetts, DOJ |
Seth H. Lundy, JD
Partner, FDA and Life Sciences, King & Spalding
|
Jim Massey, MS
Chief Sustainability Officer, Zai Lab |
Chris Matteson
Senior Manager, EY |
Kirstin Mayer, JD
Head of US Compliance, Argenx
|
Gregory F. Noonan, JD
Partner, Hogan Lovells; Former AUSA, Massachusetts & Southern District of California |
Katherine Norris, MPA
Managing Director, Epsilon Life Sciences |
Kristen Oberg, JD
Senior Vice President, Legal & Compliance, Mycovia Pharmaceuticals
|
Chelsea Ott, JD
Director, Global Regulatory, MedPro Systems |
Danielle Pelot, JD
Partner, Choate, Hall & Stewart LLP |
Zoe Philippides, JD
Senior Vice President, Chief Ethics, Compliance & Privacy Officer, Moderna
|
Susan Pietras
Global Head of Training, Communication and Policies CHC, Sanofi |
Lawrence P. Platkin, JD
Vice President and Head, U.S. Office of Compliance, Bayer US |
Nikki Reeves, JD
Partner & Co-chair, Life Sciences and Healthcare Industry Group, King & Spalding
|
Howard Root, JD
Chairman, Reprise Biomedical; Former, CEO & Co-Founder, Vascular Solutions |
Jeff Rosenbaum, MBA
Partner & Co-Founder, Dovetail Consulting Group |
Paul Silver
Principal, Regulatory & Compliance Life Sciences Leader, Deloitte Advisory
|
Tim Slone, MS, HCCP
Vice President, Global Compliance, Novavax |
Kaarthick Subramanian, MBA
Vice President, Security and Privacy, ComplyScore; Vice President, Atlas Systems |
Kelly J. Tope, JD, MBA
Head of USBU Ethics & Compliance Monitoring and Reporting Operations, Takeda
|
Annalisa Torrente-Haney, MS
Associate Director, Contract to Pay Operations US Business Partner, AstraZeneca |
Beth P. Weinman, JD
Counsel, Ropes & Gray; Former Associate Chief Counsel, FDA
|
Justin Will, JD
Global Commercial Compliance Consulting & Managed Services Practice Leader, IQVIA |
Ronald L. Wisor, Jr, JD
Partner, Hogan Lovells
|
|
|
|
|
SPONSORED BY
|
The Pharmaceutical Compliance Forum (PCF) is a coalition of compliance professionals including compliance officers and senior legal counsels from 100+ distinguished researched-based pharmaceutical manufacturers and biotech companies.
|
|
GRANTORS
|
|
GOLD
|
|
|
SILVER
|
|
|
BRONZE
|
|
|
MEDIA PARTNERS:
|
|
|
TUITION SCHOLARSHIPS:
|
The Pharma & Medical Device Congress is now offering a limited number of partial and full Tuition Scholarships to qualifying representatives of government, consumer advocate organizations, academics, students, representatives of health services research organizations, and those who have lost their jobs as a result of the COVID-19 pandemic.
Click here for more information.
|
|
|
PCF EXECUTIVE COMMITTEE
|
Joe Zimmerman
Senior Vice President, Chief Compliance Officer, SpringWorks Therapeutics
(PCF Chair) |
Christie Camelio
Chief Compliance and Risk Officer, EQRx |
Jill Dailey, JD
Vice President & Chief Compliance Officer, Incyte
|
Joshua Marks, JD
Vice President, Chief Ethics & Compliance Officer, Boehringer Ingelheim |
Margaret Sparks, JD
Head of Compliance, Vaccines & North America Ethics and Business Integrity, Sanofi |
Donna White, CCEP
Vice President, Compliance, Chiesi
|
|
|
MEDICAL DEVICE STEERING COMMITTEE CO CHAIRS
|
Sujata Dayal, JD
Vice President & Global Chief Compliance Officer, Medline Industries, Inc. |
Tara Shewchuk, JD
Chief Ethics & Compliance Officer, Medtronic |
Daniel Spicehandler, JD
Vice President Compliance, Commercial Divisions, Stryker
|
|
|
CONGRESS EXHIBIT & SPONSORSHIP INFORMATION
|
|
For sponsorship and exhibit information contact Suzanne Tyler, Exhibit Manager, at (206) 244-4861 phone, (206) 319-5303 fax, or exhibits@hcconferences.com.
|
|
FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS
|
For changes or additions, please email your request to: listmgr@PharmaUpdateNewsService.com.
For removal of your e-mail address, please click the link below for "SafeUnsubscribe" to automatically remove your address from the list.
|
|
|
